Prescribing Patterns of Disease Modifying Therapies in Late-Onset MS

Exploring the prescribing patterns of disease modifying therapies in late-onset MS patients, noting surprising high prescription rates despite lack of evidence for effectiveness in older MS patients. Emphasis on differences in prescription rates between relapsing-remitting and progressive onset patients, highlighting the challenges and need for further study on therapy impact on disease progression.